Christine Klaus

Christine Klaus has a diverse work experience in the biotech industry. Christine started their career at TKT as a Research and Development Specialist from 2000 to 2003. Christine then joined Genzyme as a Senior Research Associate from 2004 to 2006. After that, they became a Principal Research Associate at Genzyme from 2007 to 2011. Christine then moved to Epizyme, where they worked as a Scientist from 2011 to 2014, and later as a Senior Scientist from 2014 to 2018. Currently, Christine works at Kymera Therapeutics. Christine started as an Associate Principal Scientist in 2018 and has since been promoted to Principal Scientist and then to their current role as Associate Director - Translational Medicine in 2022.

Christine Klaus holds a B. Sc. degree in Molecular, Cellular, Developmental Biology from the University of New Hampshire. No specific start or end years are provided for this education.